Home
Conditions
Telangiectasia, Hereditary Hemorrhagic

Clinical trial condition

Telangiectasia, Hereditary Hemorrhagic

Explore clinical trials studying Telangiectasia, Hereditary Hemorrhagic. Study availability and eligibility vary by location and protocol.

19 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Telangiectasia, Hereditary Hemorrhagic trial results

Recruiting

Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients

NCT04976036

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +18 more
Locations: Lyon University Hospital, Dpt of genetics Bron, France

Clermont-Ferrand university hospital Clermont-Ferrand, France

Angiology Department, Lausanne University Hospital Lausanne, Canton of Vaud, Switzerland

View Trial Details

Recruiting

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

NCT00230685

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +9 more
Locations: Respiratory Medicine, Hammersmith Hospital London, United Kingdom

View Trial Details

Recruiting

Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families

NCT00230620

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +9 more
Locations: Imperial College Hammersmith Campus London, United Kingdom

View Trial Details

Active, not recruiting

Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database

NCT05933330

Conditions: Arteriovenous Malformations, Brain Diseases, Cardiovascular Abnormalities, +18 more
Locations: Danish HHT-center. Odense University Hospital Odense, Fyn, Denmark

View Trial Details

Active, not recruiting

Studies of White Blood Cells Derived From HHT Patients

NCT00230633

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +9 more
Locations: Imperial College Hammersmith Campus London, United Kingdom

View Trial Details

Completed

Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose

NCT02157987

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +18 more
Locations: CHU de Caen Caen, France

View Trial Details

Completed

Diagnostic Value of Ultra-low Dose Thoracic Scanner for the Pulmonary Arteriovenous Malformation Detection in HHT Patient

NCT04108052

Conditions: Arteriovenous Malformations, Cardiovascular Abnormalities, Cardiovascular Diseases, +15 more
Locations: Hospices Civils de Lyon - Hopital Louis Pradel Bron, France

View Trial Details

Completed

Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)

NCT02484716

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
Locations: Hospices Civils de Lyon - Hôpital Femme Mère Enfant / Service de génétique Clinique Bron, France

View Trial Details

Completed

BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT).

NCT03227263

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
Locations: CHU d'Angers Angers, France

Hôpital Ambroise Paré Boulogne-Billancourt, France

Hôpital Femme Mère Enfant Bron, France

CHU de Montpellier Hôpital St Eloi Montpellier, France

View Trial Details

Completed

Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease.

NCT03954782

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
Locations: CHU d'Angers Angers, France

Hôpital Femme-Mère-Enfant-Centre de Référence pour la maladie de Rendu-Osler Bron, France

CHU Clermont Ferrand Clermont-Ferrand, France

CHU de Marseille-Hôpital la conception Marseille, France

View Trial Details

Telangiectasia, Hereditary Hemorrhagic

Telangiectasia, Hereditary Hemorrhagic trial results

Related conditions